Recurrent Malignant Peripheral Nerve Sheath Tumor
5 clinical trials · Condition
◉ Watch Recurrent Malignant Peripheral Nerve Sheath Tumor
| Record | Firm | Date |
|---|---|---|
| Donor Stem Cell Transplant After Chemotherapy for the Treatment of Recurrent or Refractory High-Risk Solid Tumors in Pediatric and Adolescent-Young Adults (NCT04530487) | M.D. Anderson Cancer Center | 2020-08-19 |
| Vaccine Therapy in Treating Patients with Malignant Peripheral Nerve Sheath Tumor That is Recurrent or Cannot Be Removed by Surgery (NCT02700230) | Mayo Clinic | 2017-03-22 |
| Sapanisertib or Pazopanib Hydrochloride in Treating Patients With Locally Advanced or Metastatic Sarcoma (NCT02601209) | National Cancer Institute (NCI) | 2015-11-30 |
| Lorvotuzumab Mertansine in Treating Younger Patients With Relapsed or Refractory Wilms Tumor, Rhabdomyosarcoma, Neuroblastoma, Pleuropulmonary Blastoma, Malignant Peripheral Nerve Sheath Tumor, or Synovial Sarcoma (NCT02452554) | Children's Oncology Group | 2015-10-12 |
| Alisertib in Treating Patients With Advanced or Metastatic Sarcoma (NCT01653028) | National Cancer Institute (NCI) | 2012-08-22 |
Track Recurrent Malignant Peripheral Nerve Sheath Tumor automatically
Every clearance here is in the API, with alerts when new ones post.